India to Arab Countries: To make Pharma Export easier

India has urged Arab countries to make it easier to export pharmaceutical products to the region and asked them to tap Indian farms to secure food supplies, as it seeks to diversify the $160 billion trade basket with the Arab bloc beyond hydrocarbons.

Indian pharma products enjoy great credibility around the world, but we do not have the same kind of recognition in most of the Arab world, because the process through which medicines are brought into your countries are very elaborate and cumbersome at times,” said Ambassador Sanjay Bhattacharyya, Secretary (Arab, OIA & CPV), Ministry of External Affairs.

Mr. Bhattacharya said market access to Indian pharma goods could be an ‘early harvest’ idea ahead of the India-Arab Partnership forum scheduled in the first week of December, after a gap of five years.

 

“We should look for an early harvest here by looking at the USFDA and GMP [Good Manufacturing Practice]-approved drugs that can come in as a first step.

India is a large producer of generics, but we also go beyond that,” he said at a meeting hosted by FICCI with Ambassadors of several Arab countries on economic opportunities between India and the Arab nations.

India-Arab trade accounts for 20% of India’s overall trade, but is still concentrated in hydrocarbons, the secretary said, mooting agriculture, technology and tourism as potential areas for diversification.

Related Posts

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

Pharma companies in a flux over Trump’s 200% tariff move on generics

Pharma companies in a flux over Trump’s 200% tariff move on generics

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’